Bayer Wins Fourth Roundup Weedkiller Trial in US
20 Junho 2022 - 3:15AM
Dow Jones News
By Ed Frankl
Bayer AG won a fourth case in the U.S. over claims that its
Roundup weedkiller causes cancer, the company said late Friday.
A jury in Jackson County, Ore., found that the Roundup
weedkiller didn't cause a man's cancer, according to the German
pharmaceutical and agro-chemicals company.
It is the fourth case in a row that Bayer has won in less than a
year, with the company dealing with a wave of claims since it took
over Monsanto Co., the product's original owner, in 2018.
"The jury's conclusions are consistent with the assessments of
expert regulators worldwide as well as the overwhelming evidence
from four decades of scientific studies concluding that Roundup can
be used safely and is not carcinogenic," Bayer said in a
statement.
Separately, however, a U.S. federal appeals court on Friday
ordered the Environmental Protection Agency to review its
assessment that glyphosate, the active ingredient in Roundup, isn't
harmful.
In a 3-0 decision, the Ninth Circuit Court of Appeals said the
EPA hadn't adequately considered whether glyphosate causes
cancer.
The previous EPA assessment is considered one of Bayer's
arguments before the U.S. Supreme Court, which is expected to
decide whether to review the company's award of $25 million in
damages to Edwin Hardeman, who said his cancer was caused by the
weedkiller.
Herbert Rude contributed to this article.
Write to Ed Frankl at edward.frankl@dowjones.com
(END) Dow Jones Newswires
June 20, 2022 02:00 ET (06:00 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Bayer (TG:BAYN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024